PTEN and T-cell non-Hodgkin lymphoma: On the other hand, heterozygous deletion of PTEN and T cell-specific PTEN-null mutation in mice lead to increased thymic cellularity and the development of not only lymphoid hyperplasia, which progresses to T cell lymphoma, but also autoimmunity likely due to impaired Fas signaling [18]–[21].